Ergot alkaloids as dopamine agonists: comparison in two rodent models.
A series of ergot alkaloids, together with the DA agonists apomorphine and piribedil, were tested for protective effects against audiogenic seizures in an inbred strain of mice (DBA/2) and for induction of circling behaviour in mice with unilateral destruction of one nigrostriatal DA pathway. The order of potency against audiogenic seizures was apomorphine greater than ergocornine greater than bromocryptine greater than ergometrine greater than LSD greater than methysergide greater than piribedil while that observed in the rotating mouse model was apomorphine greater than ergometrine greater than ergocornine greater than bromocryptine greater than piribedil. LSD caused only weak circling behaviour even when administered in high doses (greater than 1 mg/kg). Methysergide was ineffective. Prior administration of the neuroleptic agent haloperidol blocked the effect of DA agonists and of ergot alkaloids in both animal models. The possible action of ergot alkaloids as DA agonists is discussed.
D000161:Acoustic Stimulation; D000818:Animals; D003342:Corpus Striatum / Q000502:physiology; D004298:Dopamine / Q000502:physiology*; D004876:Ergot Alkaloids / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006892:Hydroxydopamines / Q000502:physiology; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D008954:Models, Biological; D011955:Receptors, Drug / Q000187:drug effects; D012640:Seizures / Q000517:prevention & control; D013239:Stereotyped Behavior / Q000187:drug effects; D013378:Substantia Nigra / Q000502:physiology
D004876:Ergot Alkaloids; D006892:Hydroxydopamines; D011955:Receptors, Drug; D004298:Dopamine